Article
Relationship Between Polymorphisms in Methotrexate Pathway Genes and Outcome of Methotrexate Treatment in a Cohort of 119 Patients with Juvenile Idiopathic Arthritis.
The Journal of rheumatology - 1 Aug 2017
Zajc Avramovič Mojca, Dolžan Vita, Toplak Nataša, Accetto Meta, Lusa Lara, Avčin Tadej
Abstract excerpt
OBJECTIVE: To identify clinical and pharmacogenetic determinants of efficacy and toxicity of methotrexate (MTX) in juvenile idiopathic arthritis (JIA) over time. METHODS: A cohort of 119 consecutive patients with JIA treated with MTX was reviewed. The Juvenile Arthritis Disease Activity Score including 71 joints was used to measure disease activity. Nonresponders were patients who did not reach a minimum of 30%...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
